Arteriosclerosis, Thrombosis, and Vascular Biology [SEP] publisher
Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.
The journal was established in 1981 as "Arteriosclerosis" (), which was published bimonthly. From 1991 to 1994 it was published monthly under the title "Arteriosclerosis and Thrombosis
Medicine and Biochemistry at the University of Ottawa.
McPherson is also an Associate Editor of Arteriosclerosis, Thrombosis, and Vascular Biology and is a member on the Editorial Boards of the Canadian Journal of Cardiology, Journal of Lipid Research, and Circulation: Cardiovascular Genetics.
Research.
She is the director of the Lipid Clinic, Ruddy Canadian Cardiovascular Genetics Centre and Atherogenomics Laboratory at the University of Ottawa Heart Institute. McPherson had led the discovery of the 9p21 genetic risk factor for cardio-vascular disease.
Honours.